Operating Lease, Liability, Current of Can-Fite BioPharma Ltd. from 01 Jan 2019 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
Can-Fite BioPharma Ltd. quarterly Operating Lease, Liability, Current in USD history and change rate from 01 Jan 2019 to 30 Jun 2025.
  • Can-Fite BioPharma Ltd. Operating Lease, Liability, Current for the quarter ending 30 Jun 2025 was $57,000, a 58% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Change (%)

Can-Fite BioPharma Ltd. Quarterly Operating Lease, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $57,000 +$21,000 +58% 30 Jun 2025 6-K 28 Aug 2025 2025 Q2
Q4 2024 $53,000 +$26,000 +96% 31 Dec 2024 6-K 28 Aug 2025 2025 Q2
Q2 2024 $36,000 -$8,000 -18% 30 Jun 2024 6-K 29 Aug 2024 2024 Q2
Q4 2023 $27,000 -$21,000 -44% 31 Dec 2023 20-F 14 Apr 2025 2024 FY
Q2 2023 $44,000 -$3,000 -6.4% 30 Jun 2023 6-K 31 Aug 2023 2023 Q2
Q4 2022 $48,000 -$5,000 -9.4% 31 Dec 2022 20-F 28 Mar 2024 2023 FY
Q2 2022 $47,000 +$4,000 +9.3% 30 Jun 2022 6-K 25 Aug 2022 2022 Q2
Q4 2021 $53,000 +$10,000 +23% 31 Dec 2021 20-F 30 Mar 2023 2022 FY
Q2 2021 $43,000 +$7,000 +19% 30 Jun 2021 6-K 26 Aug 2021 2021 Q2
Q4 2020 $43,000 +$7,000 +19% 31 Dec 2020 20-F 24 Mar 2022 2021 FY
Q2 2020 $36,000 30 Jun 2020 6-K 27 Aug 2020 2020 Q2
Q4 2019 $36,000 +$17,000 +89% 31 Dec 2019 20-F 25 Mar 2021 2020 FY
Q4 2018 $19,000 01 Jan 2019 6-K 01 Jun 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.